CZ5-26991-22997
6 vaccinations
3 coded responses
28 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 300 / GA
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-02-11
Registered in v-safe
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-04-30
- 2021-07-30
-
2021-08-14
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-11-13
-
2022-01-05
Dose 4 — Moderna
- 2022-02-12
-
2022-05-15
Dose 5 — Pfizer-BioNTech
-
2022-08-14
Survey response — 12 months, dose 3MedDRA: Impaired work ability, Nasopharyngitis, Respiratory symptom, SARS-CoV-2 test positive — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID BINAX RAT positive Aug 4, 2022, seven days of viral upper respiratory sx "head cold " RX beginning Aug 4 with 5 day PAXLOVID . Now better RAT negative x 2 successive days. I am a USGOV physician who teleworks from home. Continued to work @home.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-14
Survey response — 3 months, dose 5MedDRA: COVID-19, Medical counselling, Nasopharyngitis, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Upper respiratory tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Covid positive upper respiratory infection "head cold" diagnosed August 4, 2022 with positive BINAX now antigen. Symptoms have resolved. Received five day course of PAXLOVID RX. Symptoms lasted seven days. Two days negative BINAX AG since recovery · Healthcare visit (other): I am a physician, consulted my own physician.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-14
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-14
Report sent to call center — 3 months, dose 5Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-15
- 2022-08-15
-
2022-10-21
Dose 6 — Pfizer-BioNTech
-
2022-10-21
Survey response — day 0, dose 6MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Health check-in — days 1–6 daily, dose 6Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2023-01-20
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-08-14 | Pfizer-BioNTech | No |
| 4 | 2022-01-05 | Moderna | No |
| 5 | 2022-05-15 | Pfizer-BioNTech | No |
| 6 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 12 — 12 months, dose 3
Symptoms: COVID BINAX RAT positive Aug 4, 2022, seven days of viral upper respiratory sx "head cold " RX beginning Aug 4 with 5 day PAXLOVID . Now better RAT negative x 2 successive days. I am a USGOV physician who teleworks from home. Continued to work @home. cut off by CDC
Release 12 — 3 months, dose 5
Symptoms: Covid positive upper respiratory infection "head cold" diagnosed August 4, 2022 with positive BINAX now antigen. Symptoms have resolved. Received five day course of PAXLOVID RX. Symptoms lasted seven days. Two days negative BINAX AG since recovery cut off by CDC
Healthcare visit (other): I am a physician, consulted my own physician.
Release 12 — day 0, dose 6
Systemic reaction (other): No
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release